During the previous week, INJ crypto, the native currency of the Injective blockchain designed for financial purposes, experienced a bullish breakout following an extended period of time. As a result, long-term investors regained control, propelling the price of INJ to surge by 10% during the morning session of the same day. This impressive performance established it as the leading gainer of the day.
Over the course of the past three weeks, the INJ token has displayed a bullish trend, resulting in a remarkable gain of over 30% to date. Notably, within the last seven trading days alone, the INJ token has surged by an impressive 27.8%, as reported by CoinMarketCap. This significant growth can be attributed to two major positive developments that have acted as catalysts for the INJ cryptocurrency.
One of these significant updates took place on 31 May when Injective made a groundbreaking announcement regarding its integration with Polygon Labs. This integration opens up new possibilities for true DeFi composability, allowing native assets from both Polygon and Injective to be utilized across a wide range of cross-chain use cases within their respective ecosystems. This collaboration marks a milestone as it enables seamless interoperability and greater flexibility for users in utilizing assets within the two interconnected ecosystems.
In recent news, Injective has announced the successful completion of The Avalon Mainnet Upgrade. This upgrade introduces the most high-performing Injective infrastructure to date, aiming to enhance the overall user experience and platform capabilities.
Market Rejuvenation: Are Buyers Making a Comeback?
Buyers appear to have reemerged in the market as the bulls take charge following a rebound just above the ascending trendline. This development has led to the breakthrough of all immediate bullish obstacles for the INJ price, which is currently trading at $7.95, reflecting an overnight gain of 10.5%.
In the past 24 hours, there has been a slight 10% increase in trading volume, reaching $74 million. Additionally, the On Balance Volume (OBV) indicator continues to remain at the high level of 342.169 million, indicating a potential retest of the annual high in the near future.
In today’s market, the bulls are making a cautious effort to keep the INJ price above all major moving averages. Notably, the 50-SMA is serving as a critical support level and an attractive buying zone for traders.
Furthermore, the RSI indicator is showing a gradual increase toward the overbought zone, currently sitting in the 62 range. These technical indicators are indicating favorable conditions for buyers to accumulate Injective (INJ) cryptocurrency, with the potential target set at the annual high of $9.97.
Also Read: Conflux (CFX) Price Plummets 14% Amidst Resistance Battle
